Latest News in the pharma Industry

Market News

Noxxon Pharma licenses and assigns preclinical  Spiegelmer programs to Aptarion

Noxxon Pharma licenses and assigns preclinical Spiegelmer programs to Aptarion

5 Jan 2017

Noxxon continues transition to clinical oncology company.

Read more 
Lonza concludes divestment of peptides business and operations in Braine-l’Alleud, Belgium

Lonza concludes divestment of peptides business and operations in Braine-l’Alleud, Belgium

4 Jan 2017

PolyPeptide Laboratories' acquisition brings immediate access to additional large-scale capacity in synthesis, purification and isolation of peptides.

Read more 
RedHill Biopharma announces exclusive US co-promotion agreement with Concordia for GI drug Donnatal

RedHill Biopharma announces exclusive US co-promotion agreement with Concordia for GI drug Donnatal

4 Jan 2017

Concordia will continue to be responsible for the manufacturing and supply of Donnatal in all territories.

Read more 
Directorate change at Shire

Directorate change at Shire

3 Jan 2017

Appointment of Ian Clark as Non-Executive Director.

Read more 
SP Scientific launches new PennTech website

SP Scientific launches new PennTech website

3 Jan 2017

Website allows visitors to simply and quickly locate pertinent information.

Read more 
Ensuring robust lyophilization scale-up

Ensuring robust lyophilization scale-up

3 Jan 2017

Presentation provides new data regarding the mechanism of the ControLyo Technology.

Read more 
Sanofi Pasteur and MSD end joint vaccines business in Europe

Sanofi Pasteur and MSD end joint vaccines business in Europe

2 Jan 2017

Each company will separately pursue their own vaccine strategies in Europe.

Read more 
Provectus Biopharmaceuticals terminates Peter Culpepper as Interim CEO and COO

Provectus Biopharmaceuticals terminates Peter Culpepper as Interim CEO and COO

29 Dec 2016

Investigation reveals improper expense reimbursements.

Read more 
Pfizer completes acquisition of small molecule anti-infective business from AstraZeneca

Pfizer completes acquisition of small molecule anti-infective business from AstraZeneca

27 Dec 2016

Agreement includes the commercialization and development rights to the newly approved EU drug Zavicefta (ceftazidime-avibactam).

Read more 
Recursion receives industry awards for drug discovery platform

Recursion receives industry awards for drug discovery platform

27 Dec 2016

Computationally intelligent drug discovery platform receives two Fierce Innovation awards for Biotech Innovation and Best New Product.

Read more 
Vectura and Mundipharma sign global development programme

Vectura and Mundipharma sign global development programme

26 Dec 2016

Development and licence agreement is for pMDI inhaled triple therapy (VR2076) for asthma and COPD.

Read more 
New pill available on the NHS for patients suffering with psoriatic arthritis

New pill available on the NHS for patients suffering with psoriatic arthritis

22 Dec 2016

Oral Otezla receives positive NICE recommendation for adults with psoriatic arthritis.

Read more